Affiliation:
1. New York University Grossman School of Medicine
2. NYU Langone Health
3. Mount Sinai School of Medicine Division of Cardiology: Icahn School of Medicine at Mount Sinai Division of Cardiology
4. New York University Medical Center: NYU Langone Health
Abstract
Abstract
Purpose: To evaluate the live birth rate (LBR) following donor frozen embryo transfer (dFET) of preimplantation genetic testing for aneuploidy (PGT-A) versus untested donor embryos, stratified by blastocyst morphologic grade (MG).
Methods: This was a retrospective cohort study of 146 patients undergoing dFET of a single euploid blastocyst from fresh or frozen oocytes using PGT-A compared to age-matched controls (1:1 ratio) who did not use PGT-A.
Primary outcome was LBR. LBR was compared amongst cohorts, with further stratification by 1) high/low MG and 2) fresh/frozen oocyte status. Secondary outcomes included perinatal outcomes.
Result(s): Median age in both groups was 44.5 years (p=0.98).
LBR was similar amongst the two cohorts (PGT-A: 57.5% vs. Untested: 50.0%, p=0.20). There was similar LBR in fresh (PGT-A: 59.2% vs. Untested: 50.0%, p=0.20) and frozen (PGT-A: 47.6% vs. Untested: 50.0%, p=0.85) oocyte subgroups.
When stratified by MG, we appreciated similar LBR amongst high qualityblastocysts (PGT-A-High: 56.5% vs. Untested-High: 52.3%, p=0.49) amongst the whole cohort, as well as in fresh (Fresh-PGT-A-High: 58.3% vs. Fresh-Untested-High: 52.9%, p=0.46) and frozen (Frozen-PGT-A-High: 44.4% vs. Frozen-Untested-High: 51.7%, p=0.59) subgroups.
Similarly, we appreciated no difference in LBR amongst low quality blastocysts (PGT-A-Low: 75.0% vs. Untested-Low: 31.2%, p=0.08) amongst the whole cohort, as well as in the fresh (Fresh-PGT-A-Low: 80.0% vs. Fresh-Untested-Low: 16.1%, p=0.08) or frozen(Frozen-PGT-A-Low: 66.7% vs. Frozen-Untested-Low: 40.0%, p=0.56) subgroups.
Gestational age (37.8 weeks, p=1.0) and infant birth weight (PGT-A: 3128.0 grams vs. Untested: 3150.2 grams, p=0.60) were similar.
Conclusion(s): PGT-A did not improve LBR regardless of blastocyst quality from fresh and previously frozen donor oocytes.
Publisher
Research Square Platform LLC
Reference29 articles.
1. Society for Assisted Reproductive Technology Third party reproduction. (n.d.). Retrieved from https://www.sart.org/ivf-info/third-party-reproduction/
2. CDC National Summary Report (2021) https://nccd.cdc.gov/drh_art/rdDownload/rdExport-147ee65e-2332-4316-afb7-a1b3e94b8249/rdDLiwhv0efhyetd5d5q4fwi35yn-f281d6628cb543c2ab170bba9196daff.pdf
3. Asch R, Balmaceda J, Ord T, Borrero C, Cefalu E, Gastaldi C, Rojas F (1987) Oocyte donation and gamete intrafallopian transfer as treatment for premature ovarian failure. Lancet. ;1(8534):687. 10.1016/s0140-6736(87)90450-8. PMID: 2882107
4. Sills ES, Brady AC, Omar AB, Walsh DJ, Salma U, Walsh AP. IVF for premature ovarian failure: first reported births using oocytes donated from a twin sister. Reprod Biol Endocrinol. ;8:31–31. doi:, Sinha P, Kuruba N (2010) Premature ovarian failure. J Obstet Gynaecol. 2007;27:16–19. doi: 10.1080/0144361060101668
5. Fresh versus cryopreserved oocyte donation;Kushnir VA;Curr Opin Endocrinol Diabetes Obes,2016